Filing metadata

Accession number
0001169245-20-000107
Form type
Form 4
Filer
PhaseBio Pharmaceuticals Inc
CIK
CIK 1169245
Filed
Nov 24, 2020
Reporting period
Nov 23, 2020
Description
Insider transaction

Explore SEC Filings Hub